RhumbLine Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $259M | Sell |
2,051,819
-184,493
| -8% | -$24.3M | 0.2% | 74 |
|
|
2026
Q1 | $312M | Sell |
2,236,312
-34,767
| -2% | -$4.87M | 0.27% | 56 |
|
|
2025
Q4 | $279M | Sell |
2,271,079
-56,787
| -2% | -$6.9M | 0.23% | 73 |
|
|
2025
Q3 | $258M | Sell |
2,327,866
-15,602
| -0.7% | -$1.77M | 0.21% | 79 |
|
|
2025
Q2 | $260M | Buy |
2,343,468
+88,328
| +4% | +$9.4M | 0.22% | 69 |
|
|
2025
Q1 | $253M | Sell |
2,255,140
-68,462
| -3% | -$7.06M | 0.24% | 69 |
|
|
2024
Q4 | $215M | Sell |
2,323,602
-39,739
| -2% | -$3.58M | 0.19% | 83 |
|
|
2024
Q3 | $198M | Sell |
2,363,341
-96,159
| -4% | -$7.34M | 0.18% | 98 |
|
|
2024
Q2 | $169M | Sell |
2,459,500
-1,038
| -0% | -$69.3K | 0.16% | 108 |
|
|
2024
Q1 | $180M | Sell |
2,460,538
-361,652
| -13% | -$27.8M | 0.17% | 103 |
|
|
2023
Q4 | $229M | Sell |
2,822,190
-39,919
| -1% | -$3.11M | 0.24% | 73 |
|
|
2023
Q3 | $214M | Buy |
2,862,109
+72,535
| +3% | +$5.58M | 0.25% | 67 |
|
|
2023
Q2 | $215M | Sell |
2,789,574
-3,176
| -0.1% | -$253K | 0.24% | 72 |
|
|
2023
Q1 | $232M | Buy |
2,792,750
+55,961
| +2% | +$4.63M | 0.29% | 63 |
|
|
2022
Q4 | $235M | Buy |
2,736,789
+42,809
| +2% | +$3.39M | 0.32% | 59 |
|
|
2022
Q3 | $166M | Buy |
2,693,980
+447,874
| +20% | +$28.2M | 0.25% | 75 |
|
|
2022
Q2 | $139M | Buy |
2,246,106
+107,019
| +5% | +$6.63M | 0.2% | 89 |
|
|
2022
Q1 | $127M | Buy |
2,139,087
+34,162
| +2% | +$2.18M | 0.16% | 108 |
|
|
2021
Q4 | $153M | Buy |
2,104,925
+37,900
| +2% | +$2.61M | 0.19% | 95 |
|
|
2021
Q3 | $144M | Sell |
2,067,025
-66,949
| -3% | -$4.7M | 0.2% | 92 |
|
|
2021
Q2 | $147M | Sell |
2,133,974
-123,970
| -5% | -$8.28M | 0.19% | 93 |
|
|
2021
Q1 | $146M | Sell |
2,257,944
-121,318
| -5% | -$7.82M | 0.2% | 96 |
|
|
2020
Q4 | $139M | Sell |
2,379,262
-131,937
| -5% | -$7.96M | 0.19% | 96 |
|
|
2020
Q3 | $159M | Sell |
2,511,199
-7,404
| -0.3% | -$513K | 0.25% | 75 |
|
|
2020
Q2 | $194M | Buy |
2,518,603
+271,391
| +12% | +$20.8M | 0.32% | 57 |
|
|
2020
Q1 | $168M | Buy |
2,247,212
+44,892
| +2% | +$3.1M | 0.35% | 54 |
|
|
2019
Q4 | $143M | Buy |
2,202,320
+28,860
| +1% | +$1.88M | 0.24% | 76 |
|
|
2019
Q3 | $138M | Buy |
2,173,460
+42,854
| +2% | +$2.8M | 0.25% | 74 |
|
|
2019
Q2 | $144M | Sell |
2,130,606
-12,759
| -0.6% | -$839K | 0.27% | 65 |
|
|
2019
Q1 | $139M | Buy |
2,143,365
+56,702
| +3% | +$3.77M | 0.27% | 68 |
|
|
2018
Q4 | $131M | Buy |
2,086,663
+1,919
| +0.1% | +$134K | 0.28% | 68 |
|
|
2018
Q3 | $161M | Sell |
2,084,744
-31,147
| -1% | -$2.35M | 0.31% | 61 |
|
|
2018
Q2 | $150M | Sell |
2,115,891
-230,447
| -10% | -$16.3M | 0.3% | 62 |
|
|
2018
Q1 | $177M | Sell |
2,346,338
-74,481
| -3% | -$5.92M | 0.37% | 50 |
|
|
2017
Q4 | $173M | Buy |
2,420,819
+100,935
| +4% | +$7.67M | 0.35% | 49 |
|
|
2017
Q3 | $188M | Sell |
2,319,884
-8,861
| -0.4% | -$678K | 0.41% | 42 |
|
|
2017
Q2 | $165M | Buy |
2,328,745
+69,843
| +3% | +$4.65M | 0.38% | 44 |
|
|
2017
Q1 | $153M | Buy |
2,258,902
+46,707
| +2% | +$3.28M | 0.36% | 45 |
|
|
2016
Q4 | $158M | Buy |
2,212,195
+54,561
| +3% | +$4.06M | 0.4% | 42 |
|
|
2016
Q3 | $171M | Buy |
2,157,634
+84,832
| +4% | +$6.89M | 0.47% | 39 |
|
|
2016
Q2 | $173M | Sell |
2,072,802
-10,650
| -0.5% | -$945K | 0.51% | 38 |
|
|
2016
Q1 | $191M | Buy |
2,083,452
+15,940
| +0.8% | +$1.44M | 0.59% | 32 |
|
|
2015
Q4 | $209M | Sell |
2,067,512
-15,694
| -0.8% | -$1.63M | 0.67% | 26 |
|
|
2015
Q3 | $205M | Buy |
2,083,206
+23,840
| +1% | +$2.65M | 0.7% | 23 |
|
|
2015
Q2 | $241M | Sell |
2,059,366
-439,849
| -18% | -$48.1M | 0.77% | 17 |
|
|
2015
Q1 | $245M | Sell |
2,499,215
-56,258
| -2% | -$5.71M | 0.71% | 22 |
|
|
2014
Q4 | $241M | Sell |
2,555,473
-51,463
| -2% | -$5.32M | 0.7% | 26 |
|
|
2014
Q3 | $278M | Sell |
2,606,936
-65,697
| -2% | -$6.43M | 0.83% | 19 |
|
|
2014
Q2 | $222M | Sell |
2,672,633
-88,811
| -3% | -$6.91M | 0.65% | 26 |
|
|
2014
Q1 | $196M | Sell |
2,761,444
-6,004
| -0.2% | -$471K | 0.58% | 32 |
|
|
2013
Q4 | $208M | Sell |
2,767,448
-115,316
| -4% | -$8.03M | 0.61% | 31 |
|
|
2013
Q3 | $181M | Sell |
2,882,764
-71,292
| -2% | -$4.26M | 0.56% | 33 |
|
|
2013
Q2 | $151M | Buy |
+2,954,056
| New | +$154M | 0.49% | 34 |
|
Other funds holding GILD
RhumbLine Advisers's GILD Position: Q2 2026 in Review
RhumbLine Advisers reduced its Gilead Sciences (GILD) stake by 8.2% in Q2 2026, selling an estimated $24.3M and leaving 2,051,819 shares worth $259M. The position accounts for 0.2% of the portfolio, ranked #74.
RhumbLine Advisers first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $312M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- RhumbLine Advisers held 2,051,819 shares of Gilead Sciences worth $259M as of Q2 2026.
- RhumbLine Advisers sold 184,493 Gilead Sciences shares in Q2 2026, an estimated $24.3M.
- Gilead Sciences made up 0.2% of RhumbLine Advisers's portfolio in Q2 2026, its #74 holding.
- RhumbLine Advisers first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Gilead Sciences position peaked at $312M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.